Michael J. Tomsicek
2021 - CRISPR Therapeutics AG
Compensation breakdown
Option Awards | $2,108,763 |
---|---|
Salary | $435,483 |
Stock Awards | $1,204,920 |
Other | $11,600 |
Total | $3,760,766 |
Tomsicek received $2.1M in option awards, accounting for 56% of the total pay in 2021.
Tomsicek also received $435.5K in salary, $1.2M in stock awards and $11.6K in other compensation.
Rankings
In 2021, Michael J. Tomsicek's compensation ranked 3,549th out of 12,415 executives tracked by ExecPay. In other words, Tomsicek earned more than 71.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,549 | 71st |
Manufacturing | 1,456 | 74th |
Chemicals And Allied Products | 590 | 75th |
Drugs | 527 | 75th |
Biological Products, Except Diagnostic Substances | 138 | 69th |
Tomsicek's colleagues
We found five more compensation records of executives who worked with Michael J. Tomsicek at CRISPR Therapeutics AG in 2021.
2021
Samarth Kulkarni
CRISPR Therapeutics AG
Chief Executive Officer
2021
Brendan Smith
CRISPR Therapeutics AG
Chief Financial Officer
2021
Tony Ho
CRISPR Therapeutics AG
Former EVP, Research and Development
2021
Lawrence Klein
CRISPR Therapeutics AG
Chief Operating Officer
2021
James Kasinger
CRISPR Therapeutics AG
General Counsel
News
April 25, 2022
April 28, 2021
April 24, 2020
April 30, 2019
June 22, 2018